Bio View Valuation
| BIOV Stock | ILS 18.40 0.80 4.55% |
At this time, the firm appears to be overvalued. Bio View shows a prevailing Real Value of S14.45 per share. The current price of the firm is S18.4. Our model approximates the value of Bio View from analyzing the firm fundamentals such as Return On Equity of 0.0399, profit margin of 0.04 %, and Current Valuation of 35.4 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Bio View's price fluctuation is somewhat reliable at this time. Calculation of the real value of Bio View is based on 3 months time horizon. Increasing Bio View's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bio View is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bio Stock. However, Bio View's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 18.4 | Real 14.45 | Hype 17.6 |
The real value of Bio Stock, also known as its intrinsic value, is the underlying worth of Bio View Company, which is reflected in its stock price. It is based on Bio View's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bio View's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bio View helps investors to forecast how Bio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bio View more accurately as focusing exclusively on Bio View's fundamentals will not take into account other important factors: About Bio View Valuation
The stock valuation mechanism determines Bio View's current worth on a weekly basis. Our valuation model uses a comparative analysis of Bio View. We calculate exposure to Bio View's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bio View's related companies.BioView Ltd. develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company was founded in 2000 and is headquartered in Rehovot, Israel. BIO VIEW is traded on Tel Aviv Stock Exchange in Israel.
8 Steps to conduct Bio View's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bio View's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bio View's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bio View's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bio View's revenue streams: Identify Bio View's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bio View's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bio View's growth potential: Evaluate Bio View's management, business model, and growth potential.
- Determine Bio View's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bio View's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Bio Stock analysis
When running Bio View's price analysis, check to measure Bio View's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio View is operating at the current time. Most of Bio View's value examination focuses on studying past and present price action to predict the probability of Bio View's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio View's price. Additionally, you may evaluate how the addition of Bio View to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |